JPRN-UMIN000035403招募中2 期
Phase IIa trial of CNT-01 for patients with idiopathic triglyceride deposit cardiomyovasculopathy. - Phase IIa trial of CNT-01 for patients with idiopathic triglyceride deposit cardiomyovasculopathy.
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients within 1 month of revascularization of coronary arteries 2) Patients with fasting serum capric acid concentration> 10 umol / L 3) Patients who had diet therapy containing medium chain fatty acid even once in the past 4) Patients with diabetic ketoacidosis 5) A pregnant patient, a pregnant woman or a lactating patient 6) Class IV patients with NYHA cardiac function classification 7) Patients with acute coronary syndrome 8) Patients with a history of drug addiction 9) Patients who are allergic to the ingredients of the CNT-01 10) Patients who are allergic to BMIPP or iodine 11) Patients with a history of clinically important drug allergic symptoms 12) Patients with severe liver dysfunction (Child-Pugh classifications B or C) 13) Patients who took part in other clinical trial studies within 3 months 14) Patients judged unsuitable for inclusion in this clinical trial
研究者
相似试验
已完成
1 期
Phase I/IIa Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyIdiopathic Triglyceride Deposit CardiomyovasculopathyJPRN-UMIN000018289Ken-ichi Hirano, Department of Cardiovascular Medicine, Osaka University Grduate School of Medicine6
进行中（未招募）
2 期
Phase IIb/III Clinical Study of CNT-01 in Patients with Idiopathic Triglyceride Deposit CardiomyovasculopathyIdiopathic triglyceride deposit cardiomyovasculopathyJPRN-jRCT2051210177Akita Yasuhiko60
已完成
1 期
Safety Study of CNT-01 in Patients With Idiopathic TGCVIdiopathic Triglyceride Deposit CardiomyovasculopathyNCT02502578Osaka University5
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
进行中（未招募）
不适用
Clinical trial in patients undergoing allo-transplant of hematopoietic stem cell (allo-HSCT) who have developed one or more post-transplant cytopeniasEUCTR2013-000534-35-ESFundación Castellano Leonesa de Hematología y Hemoterapia (FUCALHH)